Bank Of New York Mellon Corp Macrogenics Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.34 - $6.98 $691,814 - $1.45 Million	207,130 New	207,130 $1.39 Million
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $60,482 - $104,890	20,094 Added 10.53%	210,979 $730,000
Q2 2022 Aug 15, 2022	SELL	$2.25 - $9.99 $17,093 - $75,894	-7,597 Reduced 3.83%	190,885 $563,000
Q1 2022 May 11, 2022	BUY	$8.12 - $16.9 $7,372 - $15,345	908 Added 0.46%	198,482 $1.75 Million
Q4 2021 Feb 11, 2022	BUY	$15.91 - $21.88 $7,445 - $10,239	468 Added 0.24%	197,574 $3.17 Million
Q3 2021 Nov 12, 2021	BUY	$19.74 - $28.7 $434,635 - $631,916	22,018 Added 12.58%	197,106 $4.13 Million
Q2 2021 Aug 11, 2021	SELL	$20.49 - $35.63 $2.28 Million - $3.97 Million	-111,363 Reduced 38.88%	175,088 $4.7 Million
Q1 2021 May 13, 2021	BUY	$18.99 - $33.2 $1.15 Million - $2.02 Million	60,818 Added 26.95%	286,451 $9.12 Million
Q4 2020 Feb 09, 2021	BUY	$19.41 - $26.0 $221,603 - $296,842	11,417 Added 5.33%	225,633 $5.16 Million
Q3 2020 Nov 12, 2020	BUY	$24.69 - $31.6 $101,475 - $129,876	4,110 Added 1.96%	214,216 $5.4 Million
Q2 2020 Aug 12, 2020	BUY	$5.2 - $29.12 $9,396 - $52,619	1,807 Added 0.87%	210,106 $5.87 Million
Q1 2020 May 06, 2020	SELL	$4.28 - $12.11 $11,573 - $32,745	-2,704 Reduced 1.28%	208,299 $1.21 Million
Q4 2019 Feb 14, 2020	BUY	$7.95 - $12.27 $175,981 - $271,608	22,136 Added 11.72%	211,003 $2.3 Million
Q3 2019 Nov 07, 2019	SELL	$12.44 - $17.48 $142,089 - $199,656	-11,422 Reduced 5.7%	188,867 $2.41 Million
Q2 2019 Aug 12, 2019	BUY	$14.51 - $19.71 $469,833 - $638,209	32,380 Added 19.28%	200,289 $3.4 Million
Q1 2019 May 14, 2019	BUY	$11.11 - $25.6 $72,926 - $168,038	6,564 Added 4.07%	167,909 $3.02 Million
Q4 2018 Feb 11, 2019	SELL	$11.75 - $21.42 $246 - $449	-21 Reduced 0.01%	161,345 $2.05 Million
Q3 2018 Nov 09, 2018	BUY	$19.26 - $23.46 $13,713 - $16,703	712 Added 0.44%	161,366 $0
Q2 2018 Aug 06, 2018	SELL	$19.78 - $24.67 $103,706 - $129,344	-5,243 Reduced 3.16%	160,654 $3.32 Million
Q1 2018 May 15, 2018	BUY	$18.89 - $32.46 $241,338 - $414,708	12,776 Added 8.34%	165,897 $4.17 Million
Q4 2017 Feb 09, 2018	BUY	$16.19 - $20.3 $2.48 Million - $3.11 Million	153,121	153,121 $2.91 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.4 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.4 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account